Chemoprevention of breast cancer with selective estrogen receptor modulators: views from broadly diverse focus groups of women with elevated risk for breast cancer
- 12 November 2001
- journal article
- Published by Wiley in Psycho‐Oncology
- Vol. 10 (6) , 521-533
- https://doi.org/10.1002/pon.547
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Home Care Requirements for Children and Adolescents With CancerJournal of Pediatric Oncology Nursing, 2000
- The use of mammography by survivors of breast cancer.American Journal of Public Health, 1998
- PHASE III, LARGE-SCALE CHEMOPREVENTION TRIALS: Approach to Chemoprevention Clinical Trials and Phase III Clinical Trial of Tamoxifen as a Chemopreventive for Breast Cancer —The US National Cancer Institute ExperienceHematology/Oncology Clinics of North America, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality RatesJNCI Journal of the National Cancer Institute, 1996
- Mammography Usage and the Health Belief ModelHealth Education Quarterly, 1992
- Final Report on the “Tuskegee Syphilis Study”Southern Medical Journal, 1974
- The Tuskegee Syphilis StudyNew England Journal of Medicine, 1973